• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.23% Nasdaq Down 0.63%

    Alkermes plc (ALKS)

    -NasdaqGS
    58.15 Down 4.11(6.60%) 4:00PM EDT
    |After Hours : 58.15 0.00 (0.00%) 4:33PM EDT
    Add to Portfolio
    Prev Close:62.26
    Open:62.96
    Bid:55.00 x 100
    Ask:64.25 x 100
    1y Target Est:69.82
    Beta:1.47
    Next Earnings Date:30-Apr-15ALKS Earnings announcement
    Day's Range:57.89 - 63.02
    52wk Range:38.49 - 75.17
    Volume:1,597,926
    Avg Vol (3m):1,390,020
    Market Cap:8.61B
    P/E (ttm):N/A
    EPS (ttm):-0.21
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ALKS

    Comparison

    Symbol% ChgMkt Cap
    ALKSDown 6.60%8.61B
    ABTDown 1.72%71.66B
    LLYDown 0.96%75.19B
    GSKUp 0.56%112.70B

    Key Statistics

    Forward P/E (1 yr):2,907.50
    P/S (ttm):14.90
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.39
    Quarterly EPS Est (Mar-15) :-0.03
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):-2.47

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alkermes Public Limited Company, an integrated biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in various therapeutic areas. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback